Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition

New Developments in Breast MRI

Oral

Body

Wednesday, 13 May 2026

Hall 1B

16:00 - 17:50

Moderators: Valeria Romeo & Mami Iima

Session Number: 502-04

CME/CE Credit Available

Similar Sessions

This session highlights impactful innovations in breast MRI in the field of lesions classification, response to therapy and outcome prediction

Skill Level: Intermediate

16:00		502-04-001. Shape Descriptors of Fibroglandular Tissue on Breast MRI and their Association with Background Parenchymal Enhancement Henry Rusinek, Artem Mikheev, Gene Kim, Samantha Heller NYU Grossman School of Medicine, New York, United States of America Impact: This pilot study shows that quantitative shape descriptors of fibroglandular tissue predict background parenchymal enhancement. Results suggest that breast tissue morphology may potentially serve as an imaging biomarker, complementing density and enhancement measures.
16:11		502-04-002. Multiparametric MRI-Based Nomogram for Predicting MVD in Breast Carcinoma Zhengtong Wang, Weiwei Wang, Zhanguo Sun, Xiuzheng Yue Impact: IVIM and DKI parameters, especially f, can noninvasively assess MVD. A combined nomogram model aids precision breast cancer care.
16:22		502-04-003. Decoding Breast Cancer Microstructure with Time-Dependent Diffusion MRI: Toward In Vivo Histology Assessment Yu Zhou, Suyu Liu, Wenbo Sun, Hao Mei, Xiaohui Chen, Jinfeng Lv, Xuan Li, Wei Chen, Thorsten Feiweier, Ming Deng, Liying Xu Zhongnan Hospital of Wuhan University, Wuhan, China Impact: Time-dependent diffusion MRI allows noninvasive assessment of breast cancer microstructure, improving diagnostic accuracy in lesion characterization and showing strong correlations with molecular subtypes and proliferative activity. It holds significant potential for clinical use in precision oncology.
16:33		502-04-004. Integrative Synthetic, Diffusion, and Perfusion MRI for Noninvasive Prediction of Breast Cancer Immunohistochemical Markers Lihua Xiang, Jie Shi, Ling Yang, Guangzheng Li The First Affiliated Hospital of Soochow University, Suzhou, China Impact: Multiparametric MRI integrating SyMRI, DISCO, and DWI enables noninvasive assessment of key breast cancer immunohistochemical markers, bridging microstructural, diffusion, and perfusion information to support personalized treatment planning and potentially reduce biopsy dependence.
16:44		502-04-005. Early Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer with Magnetic Resonance Fingerprinting Holly Marshall, Ananya Panda, Yilun Sun, Armanda Amin, Bahar Moftakhar, Nicole Seiberlich, Donna Plecha, Vikas Gulani, Mark Griswold, Chris Flask, Yong Chen University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States of America Impact: The findings in this study suggest that breast Magnetic Resonance Fingerprinting has the potential for early assessment of response to neoadjuvant chemotherapy in breast cancer treatment and to guide treatment modifications to improve patient outcomes.
16:55		502-04-006. Advanced Diffusion-Weighted Imaging Markers for Prediction of Breast Cancer Treatment Response in a Multisite Trial Debosmita Biswas, Chen Shen, Dariya Malyarenko, Patrick Bolan, Stephane Loubrie, Isabella Li, Anum Kazerouni, Brendon Moloney, Xin Li, Dallas Turley, Marissa Lawson, Rebecca Rakow-Penner, Jennifer Specht, Suzanne Dintzis, Habib Rahbar, Thomas Chenevert, James Holmes, Wei Huang, Savannah Partridge University of Washington, Seattle, United States of America Impact: Diffusion-weighted imaging markers demonstrate accurate early prediction of pathologic response in breast tumors treated with neoadjuvant chemotherapy, outperforming RECIST. Results support their potential as imaging biomarkers to help optimize breast cancer treatments in the future.
17:06		502-04-007. Prediction of Sentinel Lymph Node Metastasis in Breast Cancer Using Intratumoral T2 Mapping and Peritumoral Edema Tianwen Xie, Yan Huang, Caixia Fu, Tom Hilbert, Tobias Kober, Weijun Peng, Yajia Gu Fudan University Shanghai Cancer Center, Shanghai, China Impact: Peritumoral edema identified on multi-echo sequence may serve as a noninvasive biomarker to stratify sentinel lymph node metastasis risk in clinically node-negative breast cancer, which may omit SLN biopsy. Further validation of T2 mapping in larger radiomic studies is warranted.
17:17		502-04-008. Association of background parenchymal enhancement suppression during neoadjuvant chemotherapy with breast cancer survival Natsuko Onishi, Wen Li, Matthew Gibbons, Lisa Wilmes, Pouya Metanat, Teffany Joy Bareng, Bonnie Joe, John Kornak, Christina Yau, I-SPY 2 Investigator Network, I-SPY2 Imaging Working Group, Laura Esserman, Nola Hylton Impact: Background parenchymal enhancement (BPE) on breast MRI may serve as an early prognostic biomarker for hormone receptor-positive breast cancer, as lack of BPE suppression early in the course of neoadjuvant chemotherapy is associated with lower distant recurrence-free survival after treatment.
17:28		502-04-009. Guided Discussion Valeria Romeo Università degli Studi di Napoli Federico II, Naples, Italy